SP2509
SYN-1212
Estimated Purity>95%
Product group Chemicals
Molecular Weight437.9
Overview
- SupplierSYNkinase
- Product NameSP2509 [1423715-09-6]
- Delivery Days Customer10
- CertificationResearch Use Only
- Estimated Purity>95%
- Molecular FormulaC19H20ClN3O5S
- Molecular Weight437.9
- Scientific DescriptionChemical. CAS: 1423715-09-6. Formula: C19H20ClN3O5S. MW: 437.9. LSD1 is a promising target for cancer therapy. Epigenetic control of histone methylation is frequently associated with oncogenesis and LSD1 is overexpressed in many types of cancer. siRNA knockdown of LSD1 has been shown to suppress growth of cancer cells. SP-2528 is a selective and reversible LSD1 inhibitor with an IC(50) of 10nM. SP-2528 demonstrates a high specificity for LSD1, with no effect on MAOi. - LSD1 is a promising target for cancer therapy. Epigenetic control of histone methylation is frequently associated with oncogenesis and LSD1 is overexpressed in many types of cancer. siRNA knockdown of LSD1 has been shown to suppress growth of cancer cells. SP-2528 is a selective and reversible LSD1 inhibitor with an IC(50) of 10nM. SP-2528 demonstrates a high specificity for LSD1, with no effect on MAOi.
- Storage Instruction2°C to 8°C
- UNSPSC12352200